ExploreWatchlistsPricing
  1. JP-listed companies
  2. Nxera Pharma Co., Ltd.
  3. Financials
  4. Total non-current liabilities

Nxera Pharma Co., Ltd. (4565)

Market cap
¥94.6B
P/E ratio
Nexera Pharma discovers, develops and commercializes innovative specialty pharmaceuticals to improve patient quality of life in Japan and worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal non-current liabilities (Million JPY)YoY (%)
Dec 31, 202556,290-16.42%
Dec 31, 202467,348-8.00%
Dec 31, 202373,203+95.79%
Dec 31, 202237,389+15.66%
Dec 31, 202132,326+53.21%
Dec 31, 202021,099+126.90%
Dec 31, 20199,299+129.55%
Dec 31, 20184,051-35.84%
Mar 31, 20186,314+25.73%
Mar 31, 20175,022-28.26%
Mar 31, 20167,000

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat